The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative Disorders.
atypical chemokine receptors
chemokines
cytokines
neurodegenerative disorders
neuroinflammation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Nov 2023
18 Nov 2023
Historique:
received:
20
10
2023
revised:
10
11
2023
accepted:
17
11
2023
medline:
27
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
Neuroinflammation is associated with several neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). Neuroinflammation provides protection in acute situations but results in significant damage to the nervous system if chronic. Overexpression of chemokines within the brain results in the recruitment and activation of glial and peripheral immune cells which can propagate a cascading inflammatory response, resulting in neurodegeneration and the onset of neurodegenerative disorders. Recent work has identified the role of atypical chemokine receptors (ACKRs) in neurodegenerative conditions. ACKRs are seven-transmembrane domain receptors that do not follow canonical G protein signaling, but regulate inflammatory responses by modulating chemokine abundance, location, and availability. This review summarizes what is known about the four ACKRs and three putative ACKRs within the brain, highlighting their known expression and discussing the current understanding of each ACKR in the context of neurodegeneration. The ability of ACKRs to alter levels of chemokines makes them an appealing therapeutic target for neurodegenerative conditions. However, further work is necessary to understand the expression of several ACKRs within the neuroimmune system and the effectiveness of targeted drug therapies in the prevention and treatment of neurodegenerative conditions.
Identifiants
pubmed: 38003682
pii: ijms242216493
doi: 10.3390/ijms242216493
pmc: PMC10671188
pii:
doi:
Substances chimiques
Receptors, Chemokine
0
Chemokines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : BYU Gerontology Center grant
ID : No grant number
Organisme : James Bobbitt Research Grant
ID : No grant number
Références
Biotechniques. 2009 Jul;47(1):625-32
pubmed: 19594447
Cell Mol Immunol. 2021 Nov;18(11):2489-2501
pubmed: 34594000
PLoS One. 2014 Dec 01;9(12):e112925
pubmed: 25437209
Int J Mol Sci. 2022 Mar 18;23(6):
pubmed: 35328727
J Exp Med. 2011 Feb 14;208(2):327-39
pubmed: 21300915
Mol Pharmacol. 2008 May;73(5):1362-70
pubmed: 18230715
Mult Scler Relat Disord. 2017 May;14:35-45
pubmed: 28619429
Brain Behav Immun. 2022 Aug;104:54-64
pubmed: 35580794
J Exp Med. 2006 Sep 4;203(9):2201-13
pubmed: 16940167
Mol Immunol. 2013 Aug;55(1):49-58
pubmed: 23253941
Glia. 2003 Mar;41(4):327-36
pubmed: 12555200
Adv Exp Med Biol. 2014;824:209-19
pubmed: 25039002
Cells. 2022 Dec 16;11(24):
pubmed: 36552863
Brain Res. 2015 Jun 22;1611:18-28
pubmed: 25770057
Eur J Immunol. 2013 Jun;43(6):1418-22
pubmed: 23580473
J Biol Chem. 2004 Jan 30;279(5):3188-96
pubmed: 14625285
Arthritis Rheum. 2004 Jun;50(6):1806-14
pubmed: 15188357
J Neuroinflammation. 2011 Dec 06;8:170
pubmed: 22145790
J Leukoc Biol. 2016 Jun;99(6):883-92
pubmed: 26740381
J Neuroinflammation. 2022 Aug 17;19(1):206
pubmed: 35978311
Front Aging Neurosci. 2022 Jun 16;14:903455
pubmed: 35783147
Nat Neurosci. 2007 Nov;10(11):1387-94
pubmed: 17965659
J Immunol. 2012 Jul 15;189(2):956-67
pubmed: 22696441
Immunity. 2018 Dec 18;49(6):1062-1076.e6
pubmed: 30446388
J Leukoc Biol. 2016 Jun;99(6):1027-33
pubmed: 26744451
Cell Rep. 2019 Feb 5;26(6):1473-1488.e9
pubmed: 30726732
Sci Rep. 2019 May 9;9(1):7178
pubmed: 31073181
Antioxidants (Basel). 2019 May 05;8(5):
pubmed: 31060341
Immunology. 2010 Apr;129(4):536-46
pubmed: 20002784
PLoS One. 2017 Nov 27;12(11):e0188305
pubmed: 29176798
Neurosci Lett. 2017 Jan 1;636:190-195
pubmed: 27840145
Cold Spring Harb Perspect Biol. 2015 Jan 29;7(5):
pubmed: 25635046
Mol Neurobiol. 2012 Jun;45(3):499-506
pubmed: 22580958
Proc Natl Acad Sci U S A. 2007 May 15;104(20):8421-6
pubmed: 17485674
Nat Immunol. 2009 Jan;10(1):101-8
pubmed: 19060902
Biochem Soc Trans. 2006 Dec;34(Pt 6):1009-13
pubmed: 17073739
PLoS One. 2016 Oct 7;11(10):e0164179
pubmed: 27716822
Front Immunol. 2020 Apr 22;11:720
pubmed: 32391018
Nat Biomed Eng. 2020 Aug;4(8):787-800
pubmed: 32747831
Mol Biol Cell. 2004 May;15(5):2492-508
pubmed: 15004236
Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):
pubmed: 28716886
Brain Pathol. 2016 Mar;26(2):248-57
pubmed: 26780491
Clin Cancer Res. 2019 Jun 15;25(12):3702-3717
pubmed: 30850359
FASEB J. 2021 Mar;35(3):e21431
pubmed: 33595155
Mol Cell Probes. 2016 Dec;30(6):386-396
pubmed: 27818248
FASEB J. 2015 Nov;29(11):4497-511
pubmed: 26139098
Immunology. 2014 Mar;141(3):302-13
pubmed: 23981039
Rheumatology (Oxford). 2017 Sep 1;56(9):1607-1617
pubmed: 28486662
Cardiovasc Res. 2015 Jun 1;106(3):478-87
pubmed: 25858253
Front Immunol. 2022 May 23;13:861931
pubmed: 35677043
Int J Mol Sci. 2022 Feb 06;23(3):
pubmed: 35163773
Lancet Neurol. 2022 Sep;21(9):830-842
pubmed: 35963264
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):
pubmed: 33875597
J Neuroinflammation. 2020 Nov 25;17(1):356
pubmed: 33239034
Front Immunol. 2012 Aug 17;3:266
pubmed: 22912641
Nature. 2008 Jul 24;454(7203):428-35
pubmed: 18650913
Trends Immunol. 2013 Jan;34(1):7-12
pubmed: 22921835
J Exp Med. 2008 Sep 29;205(10):2207-20
pubmed: 18794339
J Pathol. 2013 Jan;229(2):168-75
pubmed: 23125030
PLoS One. 2016 Dec 14;11(12):e0167201
pubmed: 27973581
Immunol Lett. 2012 Jul 30;145(1-2):30-8
pubmed: 22698181
Viruses. 2020 Jun 13;12(6):
pubmed: 32545816
J Biol Chem. 2018 Jan 19;293(3):893-905
pubmed: 29180449
Mol Cell Neurosci. 2017 Dec;85:105-118
pubmed: 28889992
Glia. 2004 Apr 1;46(1):84-94
pubmed: 14999816
Cold Spring Harb Perspect Biol. 2015 Jan 05;7(1):a020412
pubmed: 25561720
Front Immunol. 2022 Sep 23;13:996469
pubmed: 36211343
Front Immunol. 2017 Jan 11;7:691
pubmed: 28123388
Cold Spring Harb Perspect Biol. 2015 Jul 01;7(8):a020537
pubmed: 26134003
Molecules. 2020 Dec 08;25(24):
pubmed: 33302541
Sci Rep. 2020 May 15;10(1):8019
pubmed: 32415244
Int J Immunopathol Pharmacol. 2014 Apr-Jun;27(2):163-7
pubmed: 25004828
Blood. 2017 Sep 7;130(10):1223-1234
pubmed: 28743719
J Neural Transm (Vienna). 2013 Oct;120(10):1463-6
pubmed: 23982272
Biochemistry. 1993 Jun 8;32(22):5733-8
pubmed: 8389192
Trends Neurosci. 2020 Mar;43(3):144-154
pubmed: 32044129
Science. 2023 Apr 7;380(6640):eabo7649
pubmed: 37023203
PLoS One. 2010 Feb 11;5(2):e9175
pubmed: 20161793
Immunology. 2014 Jan;141(1):111-22
pubmed: 24116850
Nutr Clin Pract. 2008 Feb;23(1):35-41
pubmed: 18203962
Nat Rev Immunol. 2006 Dec;6(12):907-18
pubmed: 17124512
Eur J Immunol. 2002 Feb;32(2):494-501
pubmed: 11828366
Semin Immunol. 2003 Oct;15(5):287-94
pubmed: 15001178
Brain Behav Immun. 2019 Nov;82:319-337
pubmed: 31505255
Folia Neuropathol. 2020;58(2):93-112
pubmed: 32729289
Blood. 2009 Jun 11;113(24):6085-93
pubmed: 19380869
J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1058-63
pubmed: 16024878
Transl Neurodegener. 2020 Nov 26;9(1):42
pubmed: 33239064
Lancet Neurol. 2021 May;20(5):385-397
pubmed: 33894193
Acta Neuropathol. 2022 Feb;143(2):179-224
pubmed: 34853891
Nat Rev Neurosci. 2023 Jan;24(1):23-39
pubmed: 36316501
Lancet Neurol. 2017 Jan;16(1):55-65
pubmed: 27979356
Neuron. 2011 Jan 13;69(1):77-90
pubmed: 21220100
Trends Pharmacol Sci. 2022 Dec;43(12):1085-1097
pubmed: 36307250
J Immunol. 2008 Sep 1;181(5):3353-63
pubmed: 18714007
J Neuroinflammation. 2020 Nov 3;17(1):328
pubmed: 33143727
Cell. 2013 Dec 5;155(6):1323-36
pubmed: 24315101
Free Radic Res. 2009 Apr;43(4):348-64
pubmed: 19241241
Front Immunol. 2023 Mar 15;14:1111960
pubmed: 37006247
J Leukoc Biol. 1996 Jan;59(1):29-38
pubmed: 8558064
Heredity (Edinb). 1950 Dec;4(3):383-9
pubmed: 14802995
Int J Mol Sci. 2017 Mar 04;18(3):
pubmed: 28273839
Nat Rev Neurol. 2021 Mar;17(3):157-172
pubmed: 33318676
J Biol Chem. 2004 Jun 11;279(24):25590-7
pubmed: 15084596
Eur J Immunol. 2006 Jul;36(7):1904-16
pubmed: 16791897
Exp Cell Res. 2011 Mar 10;317(5):674-84
pubmed: 21056554
Nat Neurosci. 2023 Jun;26(6):942-954
pubmed: 37231108
Pharmacol Rev. 2013 Nov 11;66(1):1-79
pubmed: 24218476
FEBS J. 2018 Aug;285(16):2944-2971
pubmed: 29637711
Brain. 2014 May;137(Pt 5):1454-69
pubmed: 24625696
Exp Cell Res. 2011 Mar 10;317(5):556-68
pubmed: 21272574
J Neuroinflammation. 2017 Aug 23;14(1):167
pubmed: 28835272
J Biol Chem. 2005 Oct 21;280(42):35760-6
pubmed: 16107333
Annu Rev Pathol. 2022 Jan 24;17:121-139
pubmed: 34606377
J Immunol. 2006 Jul 1;177(1):17-21
pubmed: 16785491
Blood. 2010 Oct 21;116(16):2942-9
pubmed: 20606167
PLoS Genet. 2014 Oct 23;10(10):e1004758
pubmed: 25340798
Blood. 2000 Sep 1;96(5):1681-4
pubmed: 10961863
Acta Neuropathol. 2010 Aug;120(2):131-43
pubmed: 20563819
J Neuroimmune Pharmacol. 2016 Mar;11(1):26-35
pubmed: 25997895
Front Aging Neurosci. 2022 Feb 16;14:815347
pubmed: 35250543
Acta Neuropathol. 2021 Apr;141(4):527-545
pubmed: 33555429
FEBS Lett. 1998 Apr 3;425(3):490-4
pubmed: 9563519
Mol Cancer. 2010 Nov 22;9:297
pubmed: 21092185
Cold Spring Harb Perspect Biol. 2020 Feb 3;12(2):
pubmed: 31451511
Brain Behav Immun Health. 2021 Oct 22;18:100370
pubmed: 34755124
Am J Transl Res. 2023 Mar 15;15(3):1654-1666
pubmed: 37056843
Front Immunol. 2023 Apr 20;14:1133394
pubmed: 37153591
J Immunol. 2014 Mar 1;192(5):2366-73
pubmed: 24470498
J Clin Invest. 1991 Oct;88(4):1362-9
pubmed: 1918386
Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4465-70
pubmed: 11904358
Biochim Biophys Acta. 2014 Nov;1843(11):2563-2582
pubmed: 24892271
Dev Cell. 2014 Sep 8;30(5):528-40
pubmed: 25203207
J Pharmacol Exp Ther. 2003 Jan;304(1):1-7
pubmed: 12490568
Cancers (Basel). 2021 Mar 02;13(5):
pubmed: 33801414